The influence of GLP-1 receptor agonists on heart failure with reduced ejection fraction has been investigated so far only by two small clinical trials, the FIGHT and the LIVE trial
Yki-JrvinenHRosenstockJDurn-GarciaSPinnettiSBhattacharyaSThiemannSet al
Slower gastric emptying
It was evaluated in a randomized phase 2 trial involving older individuals who had experienced a fall due to reduced muscle strength.[69] In contrast to MYO-029, which was found to be safe but insufficiently effective in producing a robust increase in muscle mass,[70] landogrozumab effectively increased lean body mass and improved overall physical performance in a geriatric population with diminished muscle strength.[69] However, due to the high similarity between MSTN and GDF11, many anti-MSTN antibodies have been reported to also bind to GDF11, raising concerns about potential side effects resulting from GDF11 inhibition
GLP-1s for Weight Loss: Why Theyre So Popular Even people without diabetes are now turning to GLP-1s
Using two groups (i.e., Semaglutide and Tirzepatide), two measurements (pre/post), a medium effect size (Cohens f = 0.25), alpha of 0.01, and 95% power, we required 76 participants